重組人神經(jīng)細胞粘附分子1(NCAM-1)(CD56)

特別提示：包括重組人神經(jīng)細胞粘附分子1(NCAM-1)(CD56)在內，本公司的所有產(chǎn)品僅可用于科研實驗，嚴禁用于臨床醫(yī)療及其他非科研用途！

產(chǎn)品名稱：重組人神經(jīng)細胞粘附分子1(NCAM-1)(CD56)
英文名稱：Recombinant Human Neural cell adhesion molecule 1
產(chǎn)品貨號：JN1577
產(chǎn)品規(guī)格：10μg|50μg|500μg|1mg

本品由我們的哺乳動物細胞表達系統(tǒng)制備而成，目的基因編碼的Leu20-Pro603在C端含有His標簽。

NCAM-1/CD56質量控制：＞95%(還原性SDS-PAGE)

NCAM-1/CD56制劑：凍干品

NCAM-1/CD56保存：
凍干蛋白置于-20℃以下可長期保存，室溫條件下可穩(wěn)定保存3周。
復溶蛋白溶液可在4～7℃保存2～7天，可分裝后置于-20℃保存三個月。

NCAM-1/CD56復溶：
打開試劑管前請先離心。
復溶濃度推薦大于100 μg/ml。
凍干蛋白請溶于ddH2O。
復溶后，請根據(jù)用量分裝凍存，避免反復凍融。

關于NCAM-1/CD56：
Neural cell adhesion molecule 1 (NCAM-1) is a single-pass type I membrane protein, it belongs to a family of membrane-bound glycoproteins that are involved in Ca2+ independent cell matrix and homophilic or heterophilic cell-cell interactions. NCAM-1 is synthesized as a 761 aa preproprecursor that contains a 19 aa signal sequence, a 722 aa GPI-linked mature region, and a 20 aa C-terminal prosegment. The molecule contains five C-2 type Ig-like domains and two fibronectin type-III domains. NCAM-1 is a cell adhesion molecule involved in neuron-neuron adhesion, neurite fasciculation, outgrowth of neurites, etc. Acting as a receptor for rabies virus, NCAM-1 in the adult brain shows a decline of sialylation relative to earlier developmental periods.

根據(jù)您的關注的重組人神經(jīng)細胞粘附分子1(NCAM-1)(CD56)，rhNCAM-1，重組神經(jīng)細胞粘附分子1，rhCD56，rCD56，重組Neural cell adhesion molecule 1，重組NCAM-1，重組人CD56，rNCAM-1，Recombinant Human Neural cell adhesion molecule 1，重組人NCAM-1，重組CD56，重組人神經(jīng)細胞粘附分子1，重組人Neural cell adhesion molecule 1，您可能還對以下產(chǎn)品有需求：
 

貨號	名稱	規(guī)格
JN0310	重組人趨化因子CX3C1(Fractalkine)	10μg|50μg|500μg|1mg
JN0861	重組人β-肌動蛋白(β-Actin)	10μg|50μg|500μg|1mg
JN0947	重組人中性粒細胞明膠酶相關脂質運載蛋白(NGAL)(LCN2)	10μg|50μg|500μg|1mg
JN1068	重組人熱休克蛋白β7(HSPB7)	10μg|50μg|500μg|1mg
JN1371	重組人Ephrin-A5	10μg|50μg|500μg|1mg
JN1624	重組小鼠CTLA-4(CD152)	10μg|50μg|500μg|1mg

關注重組人神經(jīng)細胞粘附分子1(NCAM-1)(CD56)，rhNCAM-1，重組神經(jīng)細胞粘附分子1，rhCD56，rCD56，重組Neural cell adhesion molecule 1，重組NCAM-1，重組人CD56，rNCAM-1，Recombinant Human Neural cell adhesion molecule 1，重組人NCAM-1，重組CD56，重組人神經(jīng)細胞粘附分子1，重組人Neural cell adhesion molecule 1的同時，為您推薦更多您可能感興趣的產(chǎn)品：



名稱：重組人趨化因子CXCL14(BRAK)
貨號：JN0291
規(guī)格：10μg|50μg|500μg|1mg
本品由我們的大腸桿菌表達系統(tǒng)制備，目的基因編碼的Ser35-Glu111表達純化而來。

CXCL14/BRAK質量控制：＞95%(還原性SDS-PAGE)。

CXCL14/BRAK制劑：凍干品

CXCL14/BRAK保存：
凍干蛋白可在-20℃長期保存，室溫也可穩(wěn)定保存3周。
復溶蛋白溶液可在4～7℃保存2～7天。
復溶后建議分裝凍存在-20℃，可保存3個月，應避免反復凍融。

CXCL14/BRAK復溶：
1、試劑開蓋前請先離心。
2、復溶濃度應大于100 μg/ml.
3、凍干蛋白溶于ddH2O中
4、復溶后根據(jù)使用量分裝保存，避免反復凍融。

關于CXCL14/BRAK：
Human Chemokine (C-X-C Motif) Ligand 14 (CXCL14) is constitutively expressed in certain normal tissues but is reduced or absent from many established tumor cell lines and human cancers. CXCL14 is known to be a chemoattractant for monocyte and dendritic cells. CXCL14 inhibits angiogenesis and exhibits antimicrobial activities. Mature human and mouse CXCL14 differ by only 2 amino acid residues.

名稱：重組人白介素1受體α(IL-1Rα)
貨號：JN0340
規(guī)格：10μg|50μg|500μg|1mg
本品由我們的大腸桿菌表達系統(tǒng)制備，目的基因編碼的Arg26-Glu177表達純化而來。

IL-1F3/IL-1Ra質量控制：＞95%(還原性SDS-PAGE)。

IL-1F3/IL-1Ra制劑：凍干品

IL-1F3/IL-1Ra保存：
凍干蛋白可在-20℃長期保存，室溫也可穩(wěn)定保存3周。
復溶蛋白溶液可在4～7℃保存2～7天。
復溶后建議分裝凍存在-20℃，可保存3個月，應避免反復凍融。

IL-1F3/IL-1Ra復溶：
1、試劑開蓋前請先離心。
2、復溶濃度應大于100 μg/ml.
3、凍干蛋白溶于ddH2O中
4、復溶后根據(jù)使用量分裝保存，避免反復凍融。

關于IL-1F3/IL-1Ra：
Interleukin-1 Receptor Antagonist (IL-1RN) is a member of the IL-1 family. Endogenous IL-1RN is produced in numerous animal disease models as well as in human autoimmune and chronic inflammatory diseases. It binds to IL-1 receptors in competition with IL-1, but does not elicit intracellular response from this binding. Its role in counteracting the proinflammatory effects of IL-1 is being studied by numerous research groups. IL-4 and IL-13 have been shown to amplify the stimulatory effect of IL1-beta on the production of soluble and intracellular forms of IL-1RN. The regulated expression of IL-1RN in various cell types has been shown to be influenced by cytokines. In synovial fibroblasts, IL-1, TNF-alpha, or PDGF markedly enhances the synthesis of IL-1RN.